CHK1 INHIBITOR SCH900776 ENHANCES ANTICANCER ACTION OF CISPLATIN AND TRAIL VIA STIMULATION OF BAK-DEPENDENT MITOCHONDRIAL PATHWAY
Authors | |
---|---|
Year of publication | 2021 |
Type | Conference abstract |
Citation |
Authors | |
---|---|
Year of publication | 2021 |
Type | Conference abstract |
Citation |